New Drug's first human test: safe or not?
NCT ID NCT04521738
First seen Nov 01, 2025 · Last updated May 10, 2026 · Updated 28 times
Summary
This early-stage study tested a single dose of an experimental drug called SAR441255 in 48 healthy adults who were lean to overweight. The main goal was to see if the drug is safe and how the body processes it. Researchers also looked at its effects on blood sugar and insulin levels. This study did not aim to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational site number 8400001
Knoxville, Tennessee, 37920, United States
Conditions
Explore the condition pages connected to this study.